Bath & Body Works, Inc. (NYSE:BBWI – Free Report) – Telsey Advisory Group raised their FY2025 EPS estimates for Bath & Body Works in a report issued on Tuesday, November 26th. Telsey Advisory Group analyst D. Telsey now anticipates that the company will post earnings per share of $3.28 for the year, up from their prior forecast of $3.24. Telsey Advisory Group has a “Outperform” rating and a $42.00 price objective on the stock. The consensus estimate for Bath & Body Works’ current full-year earnings is $3.18 per share. Telsey Advisory Group also issued estimates for Bath & Body Works’ Q4 2025 earnings at $2.07 EPS, Q2 2026 earnings at $0.45 EPS and Q3 2026 earnings at $0.59 EPS.
Several other research firms have also commented on BBWI. Wells Fargo & Company raised their price target on shares of Bath & Body Works from $32.00 to $38.00 and gave the company an “equal weight” rating in a report on Tuesday. UBS Group cut their target price on shares of Bath & Body Works from $52.00 to $38.00 and set a “neutral” rating on the stock in a research note on Thursday, August 29th. Raymond James decreased their price target on shares of Bath & Body Works from $51.00 to $42.00 and set an “outperform” rating for the company in a research report on Thursday, August 29th. Piper Sandler increased their price target on Bath & Body Works from $35.00 to $36.00 and gave the company a “neutral” rating in a report on Tuesday. Finally, Barclays boosted their price objective on Bath & Body Works from $28.00 to $34.00 and gave the stock an “underweight” rating in a research note on Tuesday. One investment analyst has rated the stock with a sell rating, six have given a hold rating and nine have issued a buy rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $41.88.
Bath & Body Works Price Performance
Bath & Body Works stock opened at $35.23 on Wednesday. The company has a market cap of $7.72 billion, a price-to-earnings ratio of 8.59, a price-to-earnings-growth ratio of 1.14 and a beta of 1.79. Bath & Body Works has a 12 month low of $26.20 and a 12 month high of $52.99. The stock’s 50-day moving average is $30.69 and its 200-day moving average is $35.74.
Bath & Body Works (NYSE:BBWI – Get Free Report) last issued its earnings results on Wednesday, August 28th. The company reported $0.37 earnings per share for the quarter, beating analysts’ consensus estimates of $0.35 by $0.02. The firm had revenue of $1.53 billion for the quarter, compared to analysts’ expectations of $1.54 billion. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%.
Institutional Inflows and Outflows
Several hedge funds have recently made changes to their positions in BBWI. First Community Trust NA bought a new position in shares of Bath & Body Works in the 2nd quarter worth about $30,000. True Wealth Design LLC lifted its holdings in Bath & Body Works by 5,270.0% in the third quarter. True Wealth Design LLC now owns 1,074 shares of the company’s stock worth $34,000 after acquiring an additional 1,054 shares during the last quarter. Livforsakringsbolaget Skandia Omsesidigt lifted its holdings in Bath & Body Works by 300.0% in the third quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,200 shares of the company’s stock worth $38,000 after acquiring an additional 900 shares during the last quarter. Wilmington Savings Fund Society FSB bought a new position in shares of Bath & Body Works during the third quarter valued at approximately $39,000. Finally, TD Private Client Wealth LLC raised its position in shares of Bath & Body Works by 24.2% during the 3rd quarter. TD Private Client Wealth LLC now owns 1,697 shares of the company’s stock worth $54,000 after purchasing an additional 331 shares during the period. Institutional investors and hedge funds own 95.14% of the company’s stock.
Insider Activity at Bath & Body Works
In other news, CEO Gina Boswell acquired 6,000 shares of the stock in a transaction that occurred on Wednesday, October 9th. The stock was purchased at an average cost of $29.64 per share, with a total value of $177,840.00. Following the completion of the acquisition, the chief executive officer now directly owns 242,987 shares in the company, valued at $7,202,134.68. This represents a 2.53 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 0.27% of the stock is currently owned by corporate insiders.
Bath & Body Works Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Friday, December 6th. Investors of record on Friday, November 22nd will be paid a $0.20 dividend. The ex-dividend date of this dividend is Friday, November 22nd. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.27%. Bath & Body Works’s dividend payout ratio (DPR) is presently 19.51%.
About Bath & Body Works
Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.
See Also
- Five stocks we like better than Bath & Body Works
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Cerence Up 155% in 2 Days: SoundHound AI’s Fierce Competitor
- What is a Dividend King?
- Why Warren Buffett Is Selling: A Look at His Latest Market Moves
- Insider Trades May Not Tell You What You Think
- Why Amazon Shares May Never Trade Below $200 Again
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.